Chemical Structure (Argatroban 01)
Argatroban Injection
Product Images NDC 83301-0062
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Argatroban (NDC 83301-0062). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mullan Pharmaceutical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Argatroban 02)
Figure 2 (Argatroban 03)
This text provides information about the comparison between INR levels when using Warfarin plus Argatroban versus when using Warfarin alone. It includes data from 24 subjects and mentions an error associated with the prediction of Warfarin INR. The information seems to be part of a study or research comparing the effectiveness of these treatments in relation to INR levels.*
Figure 3 (Argatroban 04)
The text provides data comparing the event-free proportion between a study group (Argatroban) and a historical control group. The study group had 160 participants with 119% censored data, while the control group had 147 participants with 90% censored data. The p-value obtained from the comparison was 0.007, indicating a statistically significant difference in event-free proportions between the two groups.*
Figure 4 (Argatroban 05)
This text provides information about a study comparing the proportion of event-free outcomes in two groups. In Study 1, the group treated with Argatroban had 144 participants, with 81 censored data. The event-free proportion between groups was statistically significant, with a p-value of 0.018.*
Principal Display Panel (50 mL Vial Carton)
This text appears to be a detailed description of a medication named Argatroban Injection, USP. It provides information on the dosage, composition, usage instructions, and storage conditions for the medication. The medication comes in a 50 mg/50 mL single-dose vial and should not be diluted prior to administration. It is specifically for intravenous infusion and should be discarded if any unused portion remains. The text also mentions the manufacturer details of the medication and emphasizes the importance of storing it within a specific temperature range. Additionally, it specifies that the solution should not be used if it appears cloudy or contains a precipitate.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
